Daniel Dilling, MD
Critical Care Medicine · Maywood, ILNPI 1659358539
Payments from drug & device makers
Across 427 payments — averaging $2907.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Therapeutics Corporation$526K
- Boehringer Ingelheim$418K
- E.r. Squibb & Sons, L.L.C.$143K
- Sanofi US Services Inc.$44K
- Amgen$31K
- Genentech USA, Inc.$31K
- plus $48K from 11 others
Across 13 payments — averaging $141.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$2K
- United Therapeutics Corporation$113
- Sanofi-aventis U.S. LLC$90
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Therapeutics Corporation | 149 | $526,177 |
| Boehringer Ingelheim | 180 | $417,625 |
| E.r. Squibb & Sons, L.L.C. | 3 | $143,397 |
| Sanofi US Services Inc. | 8 | $44,290 |
| Amgen(2 entities) | 3 | $31,376 |
| Genentech USA, Inc. | 28 | $30,532 |
| Roche Products Limited | 2 | $19,431 |
| Genentech, Inc. | 2 | $16,060 |
| Boehringer Ingelheim International GmbH | 21 | $8,674 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,980 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 14 | $781 |
| Boehringer Ingelheim Limited | 8 | $762 |
| Paragonix Technologies, Inc. | 4 | $282 |
| Sanofi-aventis U.S. LLC | 1 | $28 |
| Kamada Ltd. | 1 | $21 |
| AstraZeneca | 1 | $16 |
| Philips North America LLC | 1 | $16 |
How this compares
$1,241,448 in reported general payments places this provider in the 95th percentile of 281 critical care medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Maywood
- Sean ForsytheMaywood$30K
- Brian ReichardtO Fallon$892K
- Michael CutticaChicago$765K
- Subramanyam ChittiveluPeoria$215K
- Karen WhiteUrbana$170K
- John RickelmanQuincy$158K
- Raul GazmuriNorth Chicago$158K
- Israel RubinsteinChicago$107K
- Marc SalaChicago$55K
- Abbas Al-QamariChicago$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.